Clinical Trials Open to People Under 18
(202 trials open to new patients)

• AADC Deficiency (1 open to new patients)
• Abnormal Glucose Tolerance (1 open to new patients)
• Activating RAS Mutation (1 open to new patients)
• Acute Hepatic Porphyria (1 open to new patients)
• Acute Intermittent Porphyria (2 open to new patients)
• Acute Lymphoblastic Leukemia (11 open to new patients)
• Acute Myeloid Leukemia (1 open to new patients)
• Acute Porphyria (1 open to new patients)
• Acute Porphyrias (1 open to new patients)
• ADA Deficiency (3 open to new patients)
• Adrenal Cortex Carcinoma (1 open to new patients)
• Aicardi Syndrome (1 open to new patients)
• ALA Dehydratase Deficient Porphyria (ADP) (1 open to new patients)
• ALK Fusion Protein Expression (1 open to new patients)
• ALK Gene Mutation (1 open to new patients)
• ALK Gene Translocation (1 open to new patients)
• Alpha Thalassemia (1 open to new patients)
• Alpha Thalassemia Major (2 open to new patients)
• Alport Syndrome (1 open to new patients)
• Amino Acid Metabolism, Inborn Errors (1 open to new patients)
• ANCA-Associated Vasculitis (1 open to new patients)
• Anemia (6 open to new patients)
• Angiomatoid Fibrous Histiocytoma (1 open to new patients)
• Anorexia (1 open to new patients)
• Aortic Stenosis (1 open to new patients)
• ASAH1 Mutation (1 open to new patients)
• Asthma (1 open to new patients)
• Astrocytoma (1 open to new patients)
• Atopic Dermatitis (Eczema) (1 open to new patients)
• Attention-Deficit/Hyperactivity Disorder (1 open to new patients)
• Attitude to Health (1 open to new patients)
• Atypical Fibroxanthoma (1 open to new patients)
• Atypical Teratoid Rhabdoid Tumor (1 open to new patients)
• Autism (1 open to new patients)
• Automimmune Diseases (1 open to new patients)
• BCR-ABL1 Fusion Protein Expression (1 open to new patients)
• Benzodiazepine Refractory Status Epilepticus (1 open to new patients)
• Beta-Thalassemia (1 open to new patients)
• Bile Acid Synthesis Disorders (1 open to new patients)
• Birth Asphyxia (1 open to new patients)
• Birth Defect (1 open to new patients)
• Blood Pressure (1 open to new patients)
• Bone Cancer (2 open to new patients)
• Bradycardia (1 open to new patients)
• BRAF Gene Mutation (1 open to new patients)
• BRAF-mutated Tumors (1 open to new patients)
• BRAF NP_004324.2:p.V600X (1 open to new patients)
• Brain Diseases, Metabolic, Inborn (1 open to new patients)
• Brain Disorders (1 open to new patients)
• Brain Stem Neoplasm (1 open to new patients)
• Brain Tumor (4 open to new patients)
• BRCA 1 Gene Mutation (1 open to new patients)
• BRCA 2 Gene Mutation (1 open to new patients)
• Breast Cancer (1 open to new patients)
• Breast Milk Substitute Intolerance (1 open to new patients)
• Breastfeeding (1 open to new patients)
• Cancer, General (3 open to new patients)
• Cardiac Anomalies (1 open to new patients)
• Cardiac Arrhythmia (1 open to new patients)
• Cardiovascular Disease (2 open to new patients)
• Cardiovascular Risk Factor (1 open to new patients)
• Cavernous Angioma, Familial (1 open to new patients)
• CD30-Positive Neoplastic Cells Present (1 open to new patients)
• Central Nervous System Anomalies (1 open to new patients)
• Central Nervous System Embryonal Tumors (1 open to new patients)
• Central Nervous System Neoplasm (11 open to new patients)
• Cerebral Cavernous Hemangioma (1 open to new patients)
• Cerebral Cavernous Malformations (1 open to new patients)
• Cerebral Palsy (1 open to new patients)
• Chemotherapeutic Agent Toxicity (1 open to new patients)
• Chronic Illness (1 open to new patients)
• CNS Malignancies (1 open to new patients)
• CNS Tumor (1 open to new patients)
• Cognitive/Functional Effects (1 open to new patients)
• Colorectal Cancer (2 open to new patients)
• Combined Immunodeficiency (2 open to new patients)
• Combined Immunodeficiency Disease, X-linked (1 open to new patients)
• Complex Congenital Heart Defect (1 open to new patients)
• Conditions Influencing Health Status (1 open to new patients)
• Congenital Heart Defects (1 open to new patients)
• Congenital Hyperinsulinism (1 open to new patients)
• Congenital Mesoblastic Nephroma (1 open to new patients)
• Contraception (1 open to new patients)
• Cutaneous Porphyrias (1 open to new patients)
• Deleterious ATM Gene Mutation (1 open to new patients)
• Deleterious RAD51C Gene Mutation (1 open to new patients)
• Deleterious RAD51D Gene Mutation (1 open to new patients)
• Dental Plaque (1 open to new patients)
• Developmental Defect (1 open to new patients)
• Developmental Delay (1 open to new patients)
• Diabetes (3 open to new patients)
• Diabetes Type 1 (3 open to new patients)
• Dislocations (1 open to new patients)
• Dislocation of Shoulder Region (1 open to new patients)
• Disorders of the Immune System (1 open to new patients)
• Dystonia (1 open to new patients)
• Eating Disorder (1 open to new patients)
• Eating Disorders in Adolescence (1 open to new patients)
• Encephalopathy (1 open to new patients)
• Environmental Exposure (1 open to new patients)
• Ependymoma (6 open to new patients)
• Epilepsy (3 open to new patients)
• Ewing Sarcoma (7 open to new patients)
• Extraskeletal Myxoid Chondrosarcoma (1 open to new patients)
• Extraskeletal Osteosarcoma (1 open to new patients)
• Farber Disease (1 open to new patients)
• Farber Lipogranulomatosis (1 open to new patients)
• Female Contraception (1 open to new patients)
• Fetal Hydrops (1 open to new patients)
• FGFR1 Gene Mutation (1 open to new patients)
• FGFR2 Gene Mutation (1 open to new patients)
• FGFR3 Gene Mutation (1 open to new patients)
• FGFR4 Gene Mutation (1 open to new patients)
• Fibrodysplasia Ossificans Progressiva (1 open to new patients)
• Fibrohistiocytic Neoplasm (1 open to new patients)
• Fibrosarcoma (1 open to new patients)
• Fibrosing Colonopathy (1 open to new patients)
• Fibrosis (3 open to new patients)
• Funnel Chest (1 open to new patients)
• Ganglioneuroblastoma (2 open to new patients)
• Gastroenteropancreatic Neuroendocrine Carcinoma (1 open to new patients)
• Gastrointestinal Anomalies (1 open to new patients)
• Gender Dysphoria (1 open to new patients)
• Genito-urinary Anomalies (1 open to new patients)
• Germ Cell Tumor (5 open to new patients)
• Giant Cell Arteritis (1 open to new patients)
• Glioblastoma (1 open to new patients)
• Glioma (13 open to new patients)
• Glomus Tumor of the Skin (1 open to new patients)
• GNA11 Gene Mutation (1 open to new patients)
• GNAQ Gene Mutation (1 open to new patients)
• Graft Versus Host Disease (1 open to new patients)
• Granulomatous Disease (1 open to new patients)
• Growth Delay (1 open to new patients)
• Gulf War Syndrome (1 open to new patients)
• Health Behavior (1 open to new patients)
• Health-Related Quality of Life (1 open to new patients)
• Heart Failure (2 open to new patients)
• Hematologic Malignancies (1 open to new patients)
• Hematological Malignancy (1 open to new patients)
• Hematopoietic Cell Transplantation Recipient (1 open to new patients)
• Hemoglobinopathy (2 open to new patients)
• Hemophilia (1 open to new patients)
• Hepatitis B (1 open to new patients)
• Hepatitis C (2 open to new patients)
• Hepatoblastoma (6 open to new patients)
• Hereditary Coproporphyria (HCP) (2 open to new patients)
• Hereditary Hemorrhagic Telangiectasia (1 open to new patients)
• High Blood Pressure (4 open to new patients)
• Hip Dysplasia (1 open to new patients)
• Hispanic Americans (1 open to new patients)
• Histiocytic Disorders (1 open to new patients)
• Histiocytosis (5 open to new patients)
• HIV/AIDS (3 open to new patients)
• Hodgkin's Lymphoma (3 open to new patients)
• HRAS Gene Mutation (1 open to new patients)
• Huntington's Disease (1 open to new patients)
• Hypoplastic Left Heart Syndrome (1 open to new patients)
• Inborn Genetic Diseases (1 open to new patients)
• Infection (1 open to new patients)
• Inflammatory Bowel Disease (2 open to new patients)
• Inflammatory Myofibroblastic Tumor (1 open to new patients)
• Influenza (1 open to new patients)
• Inherited Abnormalities of Platelets (1 open to new patients)
• Inherited Disorders of Metabolism (1 open to new patients)
• Insomnia (1 open to new patients)
• Instability, Shoulder (1 open to new patients)
• Intellectual Disability (1 open to new patients)
• Intermittent Exotropia (1 open to new patients)
• Invasive Candidiasis (1 open to new patients)
• Irritable Bowel Syndrome (1 open to new patients)
• Juvenile Idiopathic Arthritis (1 open to new patients)
• Juvenile Xanthogranuloma (1 open to new patients)
• Kidney Cancer (2 open to new patients)
• Kidney Disease (2 open to new patients)
• Kidney Transplant (1 open to new patients)
• KMT2A Gene Rearrangement (1 open to new patients)
• KRAS Gene Mutation (1 open to new patients)
• Langerhans Cell Histiocytosis (6 open to new patients)
• Large Cell Neuroendocrine Carcinoma (1 open to new patients)
• Leaky SCID (2 open to new patients)
• Leiomyosarcoma (1 open to new patients)
• Lennox Gastaut Syndrome (1 open to new patients)
• Leukemia (15 open to new patients)
• Liposarcoma (1 open to new patients)
• Liver Cancer (1 open to new patients)
• Liver Disease (1 open to new patients)
• Liver Transplant (1 open to new patients)
• Lower Respiratory Tract Infections (1 open to new patients)
• Lung Cancer (1 open to new patients)
• Lymphadenopathy (1 open to new patients)
• Lymphoma (16 open to new patients)
• Malignant Cutaneous Granular Cell Tumor (1 open to new patients)
• Malignant Neoplasm (2 open to new patients)
• Malignant Peripheral Nerve Sheath Tumor (1 open to new patients)
• Malignant Solid Neoplasm (10 open to new patients)
• Malignant Triton Tumor (1 open to new patients)
• Matched Targeted Therapy (1 open to new patients)
• MECP2 Duplication Syndrome (1 open to new patients)
• Medullary Thyroid Cancer (2 open to new patients)
• Medulloblastoma (7 open to new patients)
• Melanoma (2 open to new patients)
• Mesenchymal Chondrosarcoma (1 open to new patients)
• Metabolic Disease (1 open to new patients)
• Microbial Colonization (1 open to new patients)
• Microscopic Polyangiitis (1 open to new patients)
• Migraine (1 open to new patients)
• Minimal Residual Disease (1 open to new patients)
• Monosomy 7 (1 open to new patients)
• Mucopolysaccharidosis (3 open to new patients)
• Multiple Anomalies (1 open to new patients)
• Multiple Congenital Anomaly (1 open to new patients)
• Multiple Myeloma (2 open to new patients)
• Myxofibrosarcoma (1 open to new patients)
• Myxoid Chondrosarcoma (1 open to new patients)
• N-Laurylsphingosine Deacylase Deficiency (1 open to new patients)
• Narcotic Addiction (1 open to new patients)
• Nausea/Vomiting (1 open to new patients)
• Neonatal Abstinence Syndrome (1 open to new patients)
• Neonatal Encephalopathy (1 open to new patients)
• Neoplasm Metastasis (1 open to new patients)
• Nerve Sheath Neoplasm (1 open to new patients)
• Neuro-Degenerative Disease (1 open to new patients)
• Neuroblastoma (19 open to new patients)
• Neuroendocrine Carcinoma (1 open to new patients)
• Neurofibromatosis Type 1 (2 open to new patients)
• Neurotoxicity (1 open to new patients)
• Newborn (1 open to new patients)
• NF1 Gene Mutation (2 open to new patients)
• Non Hodgkin Lymphoma (10 open to new patients)
• NRAS Gene Mutation (1 open to new patients)
• NUT Midline Carcinoma (1 open to new patients)
• Obesity (3 open to new patients)
• Omenn Syndrome (2 open to new patients)
• Osteoid Osteoma (1 open to new patients)
• Osteosarcoma (7 open to new patients)
• Ovarian Cancer (1 open to new patients)
• Patient Safety (1 open to new patients)
• Peanut Allergy (1 open to new patients)
• PEComa (1 open to new patients)
• Pectus Excavatum (1 open to new patients)
• Pentalogy of Cantrell (1 open to new patients)
• Pericytic Neoplasm (1 open to new patients)
• Peripheral Primitive Neuroectodermal Tumor (3 open to new patients)
• Philadelphia Chromosome Positive (1 open to new patients)
• Physical Activity (1 open to new patients)
• Pineal Region Neoplasm (1 open to new patients)
• Plexiform Fibrohistiocytic Tumor (1 open to new patients)
• Pollution Related Respiratory Disorder (1 open to new patients)
• Polyarteritis Nodosa (1 open to new patients)
• Premature Birth of Newborn (1 open to new patients)
• Prematurity (1 open to new patients)
• Preterm Infant (1 open to new patients)
• Prion Diseases (1 open to new patients)
• Procedures Requiring Anesthesia (1 open to new patients)
• Prostate Cancer (3 open to new patients)
• Psoriasis (1 open to new patients)
• PTPN11 Gene Mutation (1 open to new patients)
• Pulmonary Vascular Disease (1 open to new patients)
• Radiation Toxicity (1 open to new patients)
• Recurrent Tumor (1 open to new patients)
• Refractory Central Nervous System Neoplasm (9 open to new patients)
• Refractory Langerhans Cell Histiocytosis (4 open to new patients)
• Refractory Malignant Solid Neoplasm (8 open to new patients)
• Refractory Osteosarcoma (1 open to new patients)
• Refractory Tumor (1 open to new patients)
• Renal Cell Carcinoma (1 open to new patients)
• Reticular Dysgenesis (2 open to new patients)
• Retinitis Pigmentosa (1 open to new patients)
• Retinitis Pigmentosa 39 (1 open to new patients)
• Rett Syndrome (1 open to new patients)
• Rhabdoid Tumor (7 open to new patients)
• Rhabdomyosarcoma (10 open to new patients)
• Rheumatic Joint Disease (1 open to new patients)
• Rheumatoid Arthritis (1 open to new patients)
• Risk Reduction (1 open to new patients)
• ROS1 Fusion Positive (1 open to new patients)
• ROS1 Gene Mutation (1 open to new patients)
• ROS1 Gene Translocation (1 open to new patients)
• RTT-related Conditions (1 open to new patients)
• Sanfilippo Syndrome (1 open to new patients)
• Sarcoma (12 open to new patients)
• SCID (2 open to new patients)
• Sclerosing Epithelioid Fibrosarcoma (1 open to new patients)
• Seminoma (1 open to new patients)
• Short Bowel Syndrome (1 open to new patients)
• Sickle Cell Anemia (7 open to new patients)
• Sinus Tachycardia (1 open to new patients)
• Skeletal Anomalies (1 open to new patients)
• Skin Cancer/Melanoma (2 open to new patients)
• Social Determinants of Health (1 open to new patients)
• Soft Tissue Sarcoma (7 open to new patients)
• Solid Neoplasm (3 open to new patients)
• Solid Tumor (18 open to new patients)
• Spinal Column Tumor (1 open to new patients)
• Spinal Cord Injury (1 open to new patients)
• Spinocerebellar Ataxia (1 open to new patients)
• Splenomegaly (1 open to new patients)
• Squamous Cell Carcinoma (1 open to new patients)
• Structural Anomalies (1 open to new patients)
• Subluxations (1 open to new patients)
• Sudden Cardiac Death (1 open to new patients)
• Supratentorial Embryonal Tumor (1 open to new patients)
• T Cell Lymphoma (1 open to new patients)
• Takayasu's Arteritis (1 open to new patients)
• Thalassemia (1 open to new patients)
• Thorax Anomalies (1 open to new patients)
• Thrombotic Microangiopathies (1 open to new patients)
• Thyroid Gland Medullary Carcinoma (1 open to new patients)
• Tracheostomy Infection (1 open to new patients)
• Traumatic Brain Injury (1 open to new patients)
• TSC1 Gene Mutation (1 open to new patients)
• TSC2 Gene Mutation (1 open to new patients)
• Urea Cycle Disorders (1 open to new patients)
• Usher Syndrome, Type 2A (1 open to new patients)
• Variegate Porphyria (VP) (2 open to new patients)
• Vaso-Occlusive Crisis (1 open to new patients)
• Veno-occlusive Disease (1 open to new patients)
• Venous Thromboembolism (1 open to new patients)
• Venous Thrombosis (1 open to new patients)
• Wegener's Granulomatosis (1 open to new patients)
• Wilms Tumor (7 open to new patients)
• Wiskott-Aldrich Syndrome (1 open to new patients)
• X-linked Retinoschisis (1 open to new patients)
• XSCID (2 open to new patients)